Replenishing Beneficial Bacteria Prevents Recurring Bacterial Vaginosis

Achieving a durable cure for recurring bacterial vaginosis can be difficult, but applications of live beneficial bacteria can help

Friday, May 15, 2020 Replenishing Beneficial Bacteria Prevents Recurring Bacterial Vaginosis, Study Shows While bacterial vaginosis can be treated with antibiotics, many infections recur after treatment. In a study published this week in The New England Journal of Medicine, NIAID-supported researchers found that an application of live beneficial bacteria could prevent this uncomfortable, painful condition from recurring. Read more about this treatment (known as LACTIN-V) on the NIAID Now blog: National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107